A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
about
The promise of neuroprotective agents in Parkinson's diseaseCoenzyme Q10 for Parkinson's diseaseCoenzyme Q10 for Parkinson's diseaseThe role of oxidative stress in Parkinson's diseaseMitochondrial dysfunction and oxidative stress in Parkinson's diseaseA review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's diseaseMitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifyingPioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month resultsEffect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.Fall frequency and risk assessment in early Parkinson's diseaseImpact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.Caffeine and progression of Parkinson diseaseCoenzyme Q10 and Neurological Diseases.Exenatide and the treatment of patients with Parkinson's diseaseBayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trialMonitoring of 30 marker candidates in early Parkinson disease as progression markers.Long term understanding of study information in research participants with Parkinson's diseaseDeterminants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods.Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease.Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices.FK506-binding protein 12 ligands: a patent review.Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.Medical management of Parkinson's disease: focus on neuroprotectionA randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy.Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With CreatineThe impact of depressive symptoms in early Parkinson disease.The futility study--Progress over the last decade.Low-Dose Aronia melanocarpa Concentrate Attenuates Paraquat-Induced Neurotoxicity.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Review of clinical trials for mitochondrial disorders: 1997-2012.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Progress in neuroprotection in Parkinson's disease.
P2860
Q21129436-F4BEDE18-7948-40B8-9AE0-67A79FB75070Q24198033-AA45C490-E7A1-4965-81E6-5F63397D4FA3Q24234491-987CE583-84DE-4527-9C5A-56A60C0A928EQ24307946-CF0F35FB-0E33-4768-9C65-5CB175F0DCBDQ27014051-C2F1CA88-6A33-4D19-AF60-9E007EAA063AQ27311651-7FBB0F8E-6340-40F9-8A01-02ABC3030E8AQ28732683-50D0147A-25B1-4EDF-A764-75EC6485A9F0Q30357397-08C3FA8F-2713-4838-BC0C-CE68002701C1Q30365907-CCE3B5EA-DF80-49A6-B4DA-F4E681B8CE83Q30395090-D44F4267-3848-47F8-8437-3390CA2849A8Q30407150-E966C7FD-394F-45F9-B342-9F235DF68C00Q30407589-5960EE10-6B30-40D8-B1C7-BF9104D895ACQ30417007-FAC0D23A-04ED-4AA2-9F6E-4A560F30763DQ30418009-25A371BC-182F-419E-95E0-66153F7F1149Q30431912-6AAEDAF1-402E-42D2-87B4-963D8B9D4CF6Q30432945-321678C6-098A-45A9-B8FD-682A26E521A6Q30440307-96CCFD33-895E-4A08-9E45-184CAFAF65A5Q30540208-7E41C945-3D86-444E-9799-95C204C267B6Q30581777-02C33890-662A-441B-97FF-C24743B9C9A4Q30783504-E9587B1D-82A2-41A8-B890-7100198B5E8BQ33635764-25E8D356-394F-4CAE-8306-7DED4F0CA80FQ33731897-88FD27EE-96CA-4060-908F-8A2AEC43CB5AQ34091447-F5CB680F-9EB3-41BF-A045-1EACE6667F92Q34174655-7E7C6330-6F84-447A-AA01-119F0D44B93BQ34272602-BE256E74-4C9B-476D-9A3C-B101F2EC079DQ34301396-EBBEFABC-9BB1-40BA-A2B2-A168085FE13DQ34423275-3B953088-4942-4462-85D4-E85CBCE1C3F4Q34955459-E1D835EB-36D5-42EC-862C-F97CDDB120EBQ35045060-D41756FF-1DC6-438E-8DC6-C3EC94112039Q35092165-E1052876-8FEA-4FFA-BF97-DBB2AF25C99BQ35443771-8815DC3F-B420-48C4-8EEB-097DB52867F4Q35785690-C7087932-073E-479B-B0FD-20F5B2011680Q36070544-67F7B87C-CC12-4B2A-A0AE-96DB3699F7D7Q36074454-166D1691-F686-427B-B932-4C5222D76208Q36264697-0968F36B-11BA-43DA-A0EB-42E5466312FAQ36386690-7DA561AE-0288-44F4-A0D2-2F59D0294975Q36499640-27C528B5-6DDA-4EE5-9C6F-F27F0F7AEAF0Q36762846-F89121DE-A7F4-4797-830F-8C19CCD38B16Q36925905-E9717CA8-4293-4F37-A64E-7E1EB06609C1Q37114112-C22AA418-5BCB-412B-AD6C-09B00482FFAF
P2860
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
@en
type
label
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
@en
prefLabel
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
@en
P1433
P1476
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
@en
P2093
NINDS NET-PD Investigators
P356
10.1212/01.WNL.0000250355.28474.8E
P407
P577
2007-01-01T00:00:00Z